Tuesday, September 6, 2016

#Bangalore based MedGenome Labs brings Non-invasive prenatal screening test (NIPT) for pregnant women

“We believe that tests such as NIPT can change the way the invasive procedures on pregnancies are administered in our country, providing the obstetrician, pregnant women and her family with insights to make informed decisions and manage the baby’s health better” said Sam Santhosh, Chairman MedGenom.

Bangalore based MedGenome a provider of genomics research services globally had received $20 million Series B investment from Sequoia Capital last year.MedGenome is a pioneer in introducing genomic technologies in India.According to MedGenome the preliminary reports on Non-invasive prenatal screening test (NIPT) on Indian population does strongly suggest that it helps obstetricians and pregnant women across age groups to better manage their pregnancy at a very early stage.